Rapid test for the detection of biological warfare agents – protection by early detection!
miPROTECT® rapid test for military, police, fire departments, and civil defense
You have already developed a rapid test, the protocols are established and now you are looking for a competent partner with the appropriate infrastructure, standardized processes and the corresponding ISO 13485 compliant QM system for the production of your rapid test?
Your search has come to an end –
please get in touch with us.
miprolab GmbH
Marie-Curie-Str. 8
37079 Göttingen
Contact
Phone: +49 (0)551 495668-0
Fax: +49 (0)551 495668-11
E-Mail: info@miprolab.com
Internet: www.miprolab.com
From the idea to prototype, to production and market launch.
With our many years of experience in managing development projects, we define the phases with you, set-up the project plan and move forward in the product development.
Our know-how and experience in development projects ensures a regulatory compliant process and quick launch of your product. We would be happy to support your business
If you have already successfully moved from the development stage to the feasibility study of your test and the production protocols are established, then you have come to the right place for the production your rapid test.
The rapid test is based on a conventional immunochromatographic reaction - the biological warfare agent to be detected is bound to a specific immobilized antibody on the rapid test via an antibody-antigen reaction. By using gold colloids, the test can be directly and easily read by the naked eye within a few minutes.
Product benefits
Rapid Tests – Toxins
miPROTECT® Ricin (Cat. No. 211)
miPROTECT® SEB (Cat. No. 212)
miPROTECT® Botulinum A (Cat. No. 213)
miPROTECT® Botulinum B (Cat. No. 216)
miPROTECT® Botulinum A/B (Cat. No. 217, Duplex)
Rapid Tests – Bacteria & Viruses
miPROTECT® Plague (Cat. No. 221)
miPROTECT® Tularemia (Cat. No. 222)
miPROTECT® Anthrax (Cat. No. 223)
miPROTECT® Pox (Cat. No. 231)
Rapid Tests - Training Tests
miPROTECT® Demo-Test (Cat. No. 219)
miPROTECT® Simili (Cat. No. 210) OVA
Sampling Devices
Sampling device A (Cat. No. 251)
Sampling device B (Cat. No. 252)
The development of the rapid tests was done on behalf of and in cooperation with the Swiss Army, the Spiez Laboratory as well as the German Armed Forces and the NBC Protection unit, Munster.